[{"address1": "429 Kent Street unit 112", "city": "Ottawa", "state": "ON", "zip": "K2P 2B4", "country": "Canada", "phone": "613-241-9959", "website": "https://www.cttpharmaceuticals.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Ryan  Khouri", "title": "Chief Executive Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Lakmaaker", "title": "Special Advisor & Senior VP of Commercial Development", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 0.02, "open": 0.02, "dayLow": 0.02, "dayHigh": 0.035, "regularMarketPreviousClose": 0.02, "regularMarketOpen": 0.02, "regularMarketDayLow": 0.02, "regularMarketDayHigh": 0.035, "beta": 0.369, "volume": 24560, "regularMarketVolume": 24560, "averageVolume": 13206, "averageVolume10days": 9854, "averageDailyVolume10Day": 9854, "bid": 0.0155, "ask": 0.0672, "marketCap": 967848, "fiftyTwoWeekLow": 0.003, "fiftyTwoWeekHigh": 0.1, "fiftyDayAverage": 0.0350372, "twoHundredDayAverage": 0.02763935, "currency": "USD", "enterpriseValue": 674628, "sharesOutstanding": 48392400, "impliedSharesOutstanding": 48392400, "bookValue": 0.035, "priceToBook": 0.57142854, "lastFiscalYearEnd": 1419984000, "nextFiscalYearEnd": 1451520000, "mostRecentQuarter": 1443571200, "netIncomeToCommon": -1670159, "lastSplitFactor": "1:10", "lastSplitDate": 1440720000, "52WeekChange": 2.4117646, "SandP52WeekChange": 0.24688339, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "CTTH", "underlyingSymbol": "CTTH", "shortName": "CTT Pharmaceutical Holdings, In", "longName": "CTT Pharmaceutical Holdings, Inc.", "firstTradeDateEpochUtc": 861370200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9c3b8fa3-3b13-3111-b1f6-b9d735df10fd", "messageBoardId": "finmb_272134495", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.02, "recommendationKey": "none", "totalCash": 32121, "totalCashPerShare": 0.002, "totalDebt": 87618, "quickRatio": 0.204, "currentRatio": 5.012, "debtToEquity": 11.871, "returnOnAssets": -1.53569, "returnOnEquity": -4.48831, "freeCashflow": -216976, "operatingCashflow": -131174, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-06"}]